MYUNGMOON Pharm co.,Ltd (017180.KS) KSC

Currency In KRW

AD

Valuation

Market Cap62.81B
Enterprise Value155.61B
P/E Ratio14.86
PEG Ratio0.04
Price/Sales Ratio0.2
Price/Book Ratio0.41
Enterprise/Revenue0.68
Enterprise/EBITDA12.33

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.02
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.03

Income Statement

Revenue195.25B
Revenue/Share5,904.3
Gross Profit107.19B
EBITDA10.13B
Net Income1.9B
Diluted EPS56.7

Balance Sheet

Total Cash4.56B
Total Cash/Share136.42
Total Debt97.74B
Total Debt/Equity1
Current Ratio0.95
Book Value Per Share3,093.29

Price History

52-Week Change-28.46
52-Week High2,055
52-Week Low1,115
Moving Average 50 Days1,434.84
Moving Average 200 Days1,691.68

Statistics

Average Volume92,284
Shares Outstanding33.43M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor513:500
Last Split DateMay 14, 2020
AD